About Noradelis

Biomedical research experience, applied to non-dilutive funding strategy.

Noradelis is an independent practice focused on non-dilutive funding strategy, reviewer-focused assessment, and scientific decision-making for biotech companies.

NIH-funded leadership

Noradelis is led by a life-science PhD who secured more than $3 million in NIH funding as a principal investigator.

Eleven years directing research

The practice draws on eleven years leading an independent biomedical research laboratory and evaluating complex scientific evidence.

Grant-review experience

Experience includes service on grant review panels for four national funding agencies in the United States and Europe.

Life-science expertise

Deep familiarity with immunology, cancer, cell biology, biochemistry, molecular biology, experimental rigor, and scientific communication informs each engagement.

The Noradelis process

Four connected stages,
one coherent strategy.

Every engagement is adapted to the company and application, but the work consistently moves through assessment, positioning, evaluation, and critical strengthening.

01

Assess

Evaluate the company, technology, funding opportunity, development stage, available evidence, timing, and constraints.

02

Position

Clarify the unmet need, innovation, scientific rationale, product-development objective, and non-dilutive funding fit.

03

Evaluate

Evaluate milestones, aims, evidence, feasibility, risks, and the proposed research plan.

04

Strengthen

Critically review the application, anticipate reviewer questions, and refine the proposal before submission or resubmission.

Your next funding decision

Discuss your funding strategy

Tell us what your company is pursuing, where you are in the process, and what decision or review you need help with.

Discuss your funding strategy